Bradykinin induced a positive chronotropic effect via stimulation of T- and L-type calcium currents in heart cells

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 3, 2003, Pages 247-258

  El Bizri, Nesrine ^a   Bkaily, Ghassan ^a   Wang, Shimin ^a   Jacques, Danielle ^a   Regoli, Domenico ^b   D'Orléans Juste, Pedro ^b   Sukarieh, Rami ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

B1 receptor; B2 receptor; Bradykinin; Ca2+; Chick heart cells; K+ currents; Na+

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; GUANINE NUCLEOTIDE BINDING PROTEIN; NIFEDIPINE; PERTUSSIS TOXIN; R 126; R 588; R 592; R 817; UNCLASSIFIED DRUG;

ANIMAL CELL; CALCIUM CURRENT; CALCIUM SIGNALING; CALCIUM TRANSPORT; CHICK EMBRYO; CHRONOTROPISM; CONFERENCE PAPER; CONTROLLED STUDY; DELAYED OUTWARD POTASSIUM CURRENT; DOSE RESPONSE; EMBRYO; FAST SODIUM INWARD CURRENT; FETUS; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INOTROPISM; ION CURRENT; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; SECOND MESSENGER; SODIUM CURRENT; VOLTAGE CLAMP;

ANILINE COMPOUNDS; ANIMALS; BRADYKININ; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, T-TYPE; CELLS, CULTURED; CHICK EMBRYO; FLUORESCENT DYES; MICROSCOPY, CONFOCAL; MYOCYTES, CARDIAC; NIFEDIPINE; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SODIUM CHANNELS; STIMULATION, CHEMICAL; TIME FACTORS; XANTHENES;

EID: 0037367821     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-045     Document Type: Conference Paper

References (37)

1. Berridge, M.J. 1993. Inositol triphosphate and calclium signaling. Nature (London), 361: 315-325.
2. Bkaily, G. 1992. Single heart cells as models for studying cardiac toxicology. In In vitro methods in toxicology. Edited by G. Jolles and A. Cordier. Academic Press, London. pp 289-334.
3. 2+ channels in vascular smooth muscle. In Ion channels in vascular smooth muscle. Edited by G. Bkaily. Medical Intelligence Unit, CRC Press, Austin, Tex. pp. 41-52.
4. 2+ current blocker in single heart cells. Am. J. Physiol. 262: H463-H471.
5. 2+ channel by PN 200-110 in heart and vascular smooth muscle. Mol. Cell. Biochem. 117: 93-106.
6. + current in fetal single centricular cells. J. Mol. Cell. Cardiol. 25: 1305-1316.
7. 2+ currents in cardiac cells. J. Cardiovasc. Pharmacol. 26: S293-S296.
8. Bkaily, G., Gros-Louis, N., Naik, R., Jaalouk, D., and Pothier, P. 1996. Implication of the nucleus in excitation contraction coupling of heart cells. Mol. Cell Biochem. 154: 113-121.
9. + transport by taurine in heart cells. Mol. Cell. Biochem. 170: 1-8.
10. Bkaily, G., Pothier, P., D'Orléans-Juste, P., Jacques, D., Simaan, M., Jaalouk, D., Belzile, F., Haddad, G., and Neugebauer, W. 1997b. The use of confocal microscopy in the investigation of cell structure and function in heart, vascular endothelium and smooth muscle cells. Mol. Cell. Biochem. 172: 171-194.
11. 2+ in aortic vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 75: 652-660.
12. Bkaily, G., Jacques, D., and Pothier, P. 1999. Use of confocal microscopy to investigate cell structure and function. Methods Enzymol. 307: 119-134.
13. Bkaily, G., Jacques, D., Hassan, G., Chouffani, S., and D'Orléans-Juste, P. 2001. Using confocal imaging to measure changes in intracellular ions. In Receptors: structure and function. Edited by C. Stanford and R. Horton. Oxford University Press, New York. pp. 209-231.
14. Bkaily, G., Massaad, D., Choufani, S., Jacques, D., and D'Orléans-Juste, P. 2002. Role of endothelin-1 receptors in the sarcolemma membrane and the nuclear membrane in the modulation of basal cytosolic and nuclear calcium levels in heart cells. Clinical Science 103: 141S-147S.
15. Bock, M.G., and Longmore, J. 2000. Bradykinin antagonist: new opportunities. Curr. Opin. Chem. Biol. 4: 401-406.
16. Conklin, B.R., Burch, R.M., Steranka, L.R., and Axelrod, J. 1988. Distinct bradykinin receptors mediate stimulation of prostaglandin synthesis by endothelial cells and fibroblasts. J. Pharmacol. Exp. Ther. 244: 646-649.
17. Dell'Italia, J.L., and Oparil, S. 1999. Bradykinin in the heart: friend or foe? Circulation, 110: 2305-2307.
18. 2+ channels in dorsal root ganglion neurons in vitro. Neuron, 2: 1185-1193.
19. Farmer, S.G., and Burch, R.M. 1991. The pharmacology of bradykinin receptors. In Bradykinin antagonists. Basic and clinical research. Edited by R.M. Burch. Marcel Dekker Inc., New York, Basel, Hong Kong. pp. 1-31.
20. Fu, T., Okana, Y., and Nozawa, Y. 1988. Bradykinin-induced generatin of inositol 1,4,5-triphosphate in fibroblasts and neuroblastma cells: effect of pertussis toxin, extracelular calcium, and down-regulation of protein kinase C. Biochem. Biophys. Res. Commun. 157: 1429-1435.
21. Furukawa, T., Ito, H., Nitta, J., Tsujinos, M., Adachi, S., Hiroe, M., Marumo, F., Sawanobori, T., and Hiraoka, M. 1992. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal ventricular myocytes. Circ. Res. 71: 1242-1253.
22. 2+ influx and the formation of endothelium-derived relaxing factor mediated by a G Protein? Eur. J. Pharmacol. 225: 43-49.
23. i to production of inositol 1,4,5-triphosphate, a second messenger in NG108-15 neuroblastoma-glioma hybrid cell. Proc. Natl. Acad. Sci. U.S.A. 83: 942-946.
24. 2+ in heart and vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 78:162-172.
25. 2 is dependent on the activation of polyphosphoinositide-hydrolyzing phospholipase C. J. Biol. Chem. 264: 4972-4977.
26. Li, Y., and Sato, T. 2001. Dual signaling via protein kinase C and phosphatidylinositol 3-kinase/AKT contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts. J. Mol. Cell. Cardiol. 33: 2047-2053.
27. 1 receptors. Immunopharmacology, 30: 1-26.
28. Moura, D., Pinheiro, H., Paiva, M.Q., and Guimaraes, S. 1999. Prejunctional effects of Angiontensin II and Bradykinin in the heart and blood vessels. J. Auton. Pharmacol. 19: 321-325.
29. Nishizuka, Y. 1988. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (London), 334: 661-665.
30. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington, D.C.), 258: 607-614.
31. Regoli, D., and Barabé, J. 1980. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32: 1-46.
32. Regoli, D., Marceau, F., and Barabé, J. 1978. De novo formation of vascular receptors for bradykinin. Can. J. Physiol. Pharmacol. 56: 674-678.
33. Rhaleb, N.E., Drapeau, G., Dion, S., Jukic, D., Rouissi, N., and Regoli, D. 1990. Structure-activity of bradykinin and related peptide. Br. J. Pharmacol. 99: 445-448.
34. Rhaleb, N.E., Rouissi, N., Drapeau, G., Jukic, D., and Regoli, D. 1991. Characterization of bradykinin receptors in peripheral organs. Can. J. Physiol. Pharmacol. 69: 938-943.
35. Rosas, R., Montague, D., Gross, M., and Bohr, D.F. 1965. Cardiac action of vasoactive polypeptides in the rat. Circ. Res. 16: 150-161.
36. Rosenkranz, A.C., Hood, S.G., Woods, R.L., Dusting G.J., and Ritchie, R.H. 2002. Acute antihypertrophic action of bradykinin in the rat heart: importance of cyclic GMP. Hypertension, 40: 498-503.
37. 2+ and protein kinase C on the cardiac T and L Ca currents. Am. J. Physiol. 261: H364-H379.